Mineralys Therapeutics, Inc. (MLYS) Tops Q3 EPS by 44c

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) reported Q3 EPS of ($0.52), $0.44 better than the analyst estimate of ($0.96).

For earnings history and earnings-related data on Mineralys Therapeutics, Inc. (MLYS) click here.

You May Also Be Interested In

• McEwen Copper seeks $1.6b in equity financing for Los Azules - Bloomberg
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
• U.S. oil producers expected to sign with PDVSA Tuesday - Politico